Broadfin Capital, LLC filings

This page lists the SEC filings reported by Broadfin Capital, LLC.

SEC filings by Broadfin Capital, LLC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2017-01-13Broadfin Capital, LLCDERMA SCIENCES, INC.00.0%EDGAR
SC 13G/A2017-01-09Broadfin Capital, LLCMirati Therapeutics, Inc.826,0014.2%EDGAR
SC 13G2017-01-09Broadfin Capital, LLCMirati Therapeutics, Inc.1,676,0016.9%EDGAR
SC 13G/A2017-01-06Broadfin Capital, LLCAVADEL PHARMACEUTICALS PLC00.0%EDGAR
SC 13G2017-01-06Broadfin Capital, LLCAVADEL PHARMACEUTICALS PLC4,394,46410.7%EDGAR
SC 13D/A2016-12-14Broadfin Capital, LLCRecro Pharma, Inc.3,100,08616.4%EDGAR
SC 13D/A2016-12-01Broadfin Capital, LLCAegerion Pharmaceuticals, Inc.00.0%EDGAR
SC 13D/A2016-12-01Broadfin Capital, LLCQLT INC/BC9,742,77010.5%EDGAR
SC 13G2016-11-21Broadfin Capital, LLCDURECT CORP8,506,2296.1%EDGAR
SC 13G2016-11-04Broadfin Capital, LLCVERACYTE, INC.1,916,6665.8%EDGAR
SC 13D/A2016-09-22Broadfin Capital, LLCQLT INC/BC5,269,83110.0%EDGAR
SC 13D/A2016-09-13Broadfin Capital, LLCQLT INC/BC4,445,5278.4%EDGAR
SC 13D/A2016-09-13Broadfin Capital, LLCAegerion Pharmaceuticals, Inc.4,286,29114.5%EDGAR
SC 13D/A2016-08-17Broadfin Capital, LLCRecro Pharma, Inc.2,450,08620.7%EDGAR
SC 13G2016-08-10Broadfin Capital, LLCMirati Therapeutics, Inc.1,000,0005.0%EDGAR
SC 13D2016-06-22Broadfin Capital, LLCQLT INC/BC4,445,5278.4%EDGAR
SC 13D2016-06-22Broadfin Capital, LLCAegerion Pharmaceuticals, Inc.4,010,29113.6%EDGAR
SC 13G2016-03-24Broadfin Capital, LLCAralez Pharmaceuticals Inc.3,800,0005.9%EDGAR
SC 13D/A2016-03-15Broadfin Capital, LLCSTRATA Skin Sciences, Inc.1,008,2979.9%EDGAR
SC 13G/A2016-03-08Broadfin Capital, LLCPERNIX THERAPEUTICS HOLDINGS, INC.6,090,82910.0%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.